Roche Affiliates Worldwide
A series of revolutionary drugs for cancer therapy are developed beginning in the mid-90s like an early customized medicine — a humanized antibody made to target and block a protein developed by a distinct gene with cancer-causing potential. Also, Roche launches a therapy for those living with the most common form of adult leukemia. The creation in 1968 of a department for diagnostic merchandise marks Roche’s entry into a new sector. The European Commission fined Roche €462 million for the…